CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for MAKO Surgical Corp. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

MAKO Surgical Corp.
2555 Davie Road
Phone: 866.647.6256p:866.647.6256 Fort Lauderdale, FL  33317  United States Ticker: MAKOMAKO

This company was Merged or Acquired on 12/17/2013.
This company ceased filing statements with the SEC on 12/27/2013.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
MAKO Surgical Corp. (MAKO) is a medical device company, which markets its advanced robotic arm solution, joint specific applications for the knee and hip and orthopedic implants for orthopedic procedures. The Company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific, osteoarthritic disease. MAKOplasty is performed using the Company's RIO Robotic Arm Interactive Orthopedic system (RIO). The RIO is a technology platform that utilizes tactile guided robotic arm technology and patient specific planning and visualization to offer reproducible precision to surgeons. In October 2013, MAKO Surgical Corp. completed the acquisition of Pipeline Biomedical Holdings, Inc.'s business, which is engaged in the design, development, manufacture and commercialization of orthopedic devices and related instruments for use with both robotic devices and manual medical procedures.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201312/31/2012YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Independent Chairman of the Board Charles W.Federico 63 6/4/2013 6/1/2007
President, Chief Executive Officer, Director Maurice R.Ferre 51 6/4/2013 11/1/2004
Chief Financial Officer, Senior Vice President - Finance and Administration, Treasurer Fritz L.LaPorte 42 2/14/2008 2/14/2008
11 additional Officers and Directors records available in full report.

Business Names
Business Name
MAKO
MAKO Surgical Corp.
Pipeline Biomedical Holdings, Inc.

General Information
Number of Employees: 436 (As of 12/31/2012)
Outstanding Shares: 51,506,301 (As of 11/12/2013)
Shareholders: 43
Stock Exchange: NASD
Federal Tax Id: 201901148
Fax Number: 954.927.0446
Email Address: contactus@makosurgical.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023